Gene therapy for diabetic peripheral neuropathy: a randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor
Alongside this, the time of day variation in stroke onset exists, where theres a significant increase in morning onset strokes (Marler et al., 1989)
At Harley Street MD, specialists assess your injury, overall health, and fitness goals to determine if peptide therapy is appropriate, and provide safe monitoring throughout treatment
We offer high-quality pharmaceutical-grade B12 injections, personalized dosing based on your bloodwork, and ongoing monitoring so you can feel your best without the worry of supplies, sharps disposal, or technique